Author: Piers Townley

The multi-award winning HeadSmart campaign has gained international recognition after being recommended to the Australian Government as a “model to inform the public about low survival rate cancers and their symptoms”

This week our Chief Scientific Officer, Dr David Jenkinson, is speaking at a meeting of the All Party Parliamentary Group on brain tumours about what risks Brexit poses

Researchers in collaboration with ZIOPHARM Oncology, a biopharmaceutical company announce positive updates on a Phase 1 clinical trials testing a new therapy

Inspired by our Community Fundraiser Shona Richardson’s personal story, Alexander Stewart MSP has tabled a debate in the Scottish Parliament on 7 December

The resources have been developed in response to a nationwide gap in information. They will improve the quality of life for those affected

Are they good for raising awareness or should the bubble burst? Our senior media & PR Officer Carol Dyce examines

Ally is an academic psychiatry trainee, nearly a Consultant psychiatrist, currently funded by The Charity to study non-drug treatments for fatigue in people living with a brain tumour

Lewis and his team headwest to raise £75,000 to help fund HeadSmart

Researchers at Glasgow University have discovered that ovarian cancer drug, olaparib, has the potential to treat patients with glioblastomas

Gideon Burrows has written his second book with personal stories, experiences, statistics and information, helped by a huge amount of people directly affected

A gene therapy to treat recurrent high-grade gliomas is accelerated to Phase 3 clinical trials, after the success of Phase 1 clinical trials by the US Food and Drug Administration (FDA)

Our Policy & Public Affairs Manager, Cameron Miller, on Australia’s Cure Brain Cancer AU$100m investment fund

A team of researchers at UCLA have discovered a combination of drugs to prevent the growth of glioblastomas, as well as kill tumour cells in mice with glioblastomas

Jonathan Canty, our Project Information Analyst, reflects on the SNP Conference in Glasgow last week

A research team at the University of Texas, led by Professor George Biros have been able to accurately characterise gliomas using a super computer

Professor Frank Winkler and his team at Heidelberg University in Germany have discovered a potential mechanism that could explain glioma recurrence

Our Policy & Public Affairs Manager Cameron Miller, reports from the Conservative Party Conference.

Researchers at The Institute of Cancer Research identify new subgroups for high-grade glial tumours occurring in children

Our Policy & Public Affairs Manager, Cameron Miller, writes from the frontline of the party conference in Brighton

Researchers at Stanford University discover that the absence of a particular protein halts the growth of high-grade gliomas

A diffuse intrinsic pontine glioma (DIPG) diagnosis can be one of the most difficult things for a parent to hear and it can leave many families feeling helpless, powerless and desperately frustrated with the devastating prognosis

Sarah Lindsell, The Charity’s Chief Executive, has co-signed a letter urging the Secretary of State for Health, Jeremy Hunt, to protect England’s largest annual survey of cancer patient experience in the NHS

We have awarded the Dutch/British WINDOW Consortium a grant of £1.5 million (€1.75 million) for research into Glioblastoma

A team of researchers investigated the effect of the Zika virus on glioblastoma cells in mice, as well as in human brain tissue samples. They discovered that the virus infected and killed the cancerous cells